Listed

Adagio Medical Holdings, Inc.

ADGMNasdaqCIK 2006986HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q2 FY2026
Operating income−$4.9m, Q2 FY2026
Net income−$6.7m, Q2 FY2026
Adagio Medical Holdings, Inc., income statement, quarterly
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31period not labelled2024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.0Revenue, period not labelled, three months to 2023-09-30$41.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-14, accession 0001558370-24-015720.Report this figure0.1Revenue, period not labelled, three months to 2023-12-31$78.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-27, accession 0001558370-25-003849. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, period not labelled, three months to 2024-03-31$26.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-15, accession 0001558370-25-007883.Report this figure0.3Revenue, Q2 FY2024, three months to 2024-06-30$254.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-14, accession 0001558370-25-011420.Report this figurenot reported0.0Revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001104659-25-110345.Report this figure0.0Revenue, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0002006986-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure0.0Revenue, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure
Cost of revenue$m0.3Cost of revenue, period not labelled, three months to 2023-09-30$253.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-14, accession 0001558370-24-015720.Report this figure0.3Cost of revenue, period not labelled, three months to 2023-12-31$334.0k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-03-27, accession 0001558370-25-003849. Derived: 12-month figure less the 9-month figure.Report this figure0.5Cost of revenue, period not labelled, three months to 2024-03-31$542.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-15, accession 0001558370-25-007883.Report this figure0.7Cost of revenue, Q2 FY2024, three months to 2024-06-30$682.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-14, accession 0001558370-25-011420.Report this figurenot reported0.3Cost of revenue, Q1 FY2025, three months to 2025-03-31$253.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure0.3Cost of revenue, Q2 FY2025, three months to 2025-06-30$342.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure0.0Cost of revenue, Q3 FY2025, three months to 2025-09-30$31.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-12, accession 0001104659-25-110345.Report this figure0.1Cost of revenue, Q4 FY2025, three months to 2025-12-31$58.0k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-03-27, accession 0002006986-26-000003. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Research and development$m4.4Research and development, period not labelled, three months to 2023-09-30$4.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001558370-24-015720.Report this figure1.8Research and development, period not labelled, three months to 2023-12-31$1.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-27, accession 0001558370-25-003849. Derived: 12-month figure less the 9-month figure.Report this figure3.5Research and development, period not labelled, three months to 2024-03-31$3.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0001558370-25-007883.Report this figure2.9Research and development, Q2 FY2024, three months to 2024-06-30$2.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001558370-25-011420.Report this figurenot reported3.7Research and development, Q1 FY2025, three months to 2025-03-31$3.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure2.0Research and development, Q2 FY2025, three months to 2025-06-30$2.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure2.8Research and development, Q3 FY2025, three months to 2025-09-30$2.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001104659-25-110345.Report this figure2.2Research and development, Q4 FY2025, three months to 2025-12-31$2.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-27, accession 0002006986-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure2.7Research and development, Q1 FY2026, three months to 2026-03-31$2.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure2.5Research and development, Q2 FY2026, three months to 2026-06-30$2.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure
Selling, general and administrative$m4.5Selling, general and administrative, period not labelled, three months to 2023-09-30$4.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-14, accession 0001558370-24-015720.Report this figure3.3Selling, general and administrative, period not labelled, three months to 2023-12-31$3.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-27, accession 0001558370-25-003849. Derived: 12-month figure less the 9-month figure.Report this figure4.8Selling, general and administrative, period not labelled, three months to 2024-03-31$4.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-15, accession 0001558370-25-007883.Report this figure3.4Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$3.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-14, accession 0001558370-25-011420.Report this figurenot reported3.5Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$3.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure2.4Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$2.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure2.9Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$2.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-12, accession 0001104659-25-110345.Report this figure1.7Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$1.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-27, accession 0002006986-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure2.5Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$2.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure2.5Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$2.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure
Operating income$m(9.1)Operating income, period not labelled, three months to 2023-09-30−$9.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001558370-24-015720.Report this figure(5.3)Operating income, period not labelled, three months to 2023-12-31−$5.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-27, accession 0001558370-25-003849. Derived: 12-month figure less the 9-month figure.Report this figure(8.8)Operating income, period not labelled, three months to 2024-03-31−$8.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0001558370-25-007883.Report this figure(6.7)Operating income, Q2 FY2024, three months to 2024-06-30−$6.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001558370-25-011420.Report this figurenot reported(7.4)Operating income, Q1 FY2025, three months to 2025-03-31−$7.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure(4.7)Operating income, Q2 FY2025, three months to 2025-06-30−$4.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure(5.7)Operating income, Q3 FY2025, three months to 2025-09-30−$5.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001104659-25-110345.Report this figure(4.0)Operating income, Q4 FY2025, three months to 2025-12-31−$4.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0002006986-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure(5.2)Operating income, Q1 FY2026, three months to 2026-03-31−$5.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure(4.9)Operating income, Q2 FY2026, three months to 2026-06-30−$4.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure
Interest expense$m0.5Interest expense, period not labelled, three months to 2023-09-30$485.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-11-14, accession 0001558370-24-015720.Report this figure0.6Interest expense, period not labelled, three months to 2023-12-31$577.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2025-03-27, accession 0001558370-25-003849. Derived: 12-month figure less the 9-month figure.Report this figure0.8Interest expense, period not labelled, three months to 2024-03-31$754.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-05-15, accession 0001558370-25-007883.Report this figure0.8Interest expense, Q2 FY2024, three months to 2024-06-30$760.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-14, accession 0001558370-25-011420.Report this figurenot reported0.7Interest expense, Q1 FY2025, three months to 2025-03-31$662.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure0.7Interest expense, Q2 FY2025, three months to 2025-06-30$720.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure0.7Interest expense, Q3 FY2025, three months to 2025-09-30$749.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-12, accession 0001104659-25-110345.Report this figure0.8Interest expense, Q4 FY2025, three months to 2025-12-31$775.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-27, accession 0002006986-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure0.8Interest expense, Q1 FY2026, three months to 2026-03-31$778.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure0.8Interest expense, Q2 FY2026, three months to 2026-06-30$805.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure
Net income$m(10.8)Net income, period not labelled, three months to 2023-09-30−$10.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001558370-24-015720.Report this figure(8.6)Net income, period not labelled, three months to 2023-12-31−$8.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-27, accession 0001558370-25-003849. Derived: 12-month figure less the 9-month figure.Report this figure(8.0)Net income, period not labelled, three months to 2024-03-31−$8.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-15, accession 0001558370-25-007883.Report this figure(5.7)Net income, Q2 FY2024, three months to 2024-06-30−$5.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-14, accession 0001558370-25-011420.Report this figure(8.2)Net income, Q3 FY2024, three months to 2024-09-30−$8.2m. XBRL concept us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic. 10-Q filed 2025-11-12, accession 0001104659-25-110345.Report this figure(7.7)Net income, Q1 FY2025, three months to 2025-03-31−$7.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure(3.9)Net income, Q2 FY2025, three months to 2025-06-30−$3.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure(10.1)Net income, Q3 FY2025, three months to 2025-09-30−$10.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001104659-25-110345.Report this figure(3.3)Net income, Q4 FY2025, three months to 2025-12-31−$3.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0002006986-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure(7.0)Net income, Q1 FY2026, three months to 2026-03-31−$7.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure(6.7)Net income, Q2 FY2026, three months to 2026-06-30−$6.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure
Diluted EPS$ per share(14.15)Diluted EPS, period not labelled, three months to 2023-09-30−$14.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001558370-24-015720.Report this figurenot reported(10.28)Diluted EPS, period not labelled, three months to 2024-03-31−$10.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0001558370-25-007883.Report this figure(7.35)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$7.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001558370-25-011420.Report this figurenot reported(0.51)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure(0.35)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure(0.66)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.66 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001104659-25-110345.Report this figurenot reported(0.31)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure(0.30)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure
Basic EPS$ per share(14.15)Basic EPS, period not labelled, three months to 2023-09-30−$14.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001558370-24-015720.Report this figurenot reported(10.28)Basic EPS, period not labelled, three months to 2024-03-31−$10.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0001558370-25-007883.Report this figure(7.35)Basic EPS, Q2 FY2024, three months to 2024-06-30−$7.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001558370-25-011420.Report this figure(8.34)Basic EPS, Q3 FY2024, three months to 2024-09-30−$8.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001104659-25-110345.Report this figure(0.50)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.50 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure(0.26)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure(0.66)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.66 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001104659-25-110345.Report this figurenot reported(0.31)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure(0.30)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure

Balance sheet

Cash and equivalents$7.7m, Q2 FY2026
Long-term debt$24.8m, Q2 FY2026
Shareholders' equity−$415.0k, Q2 FY2026
Adagio Medical Holdings, Inc., balance sheet, quarterly
Line itemUnitperiod not labelled2023-12-31period not labelled2024-03-31Q2 FY20242024-06-30period not labelled2024-07-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m1.4Cash and equivalents, period not labelled, at 2023-12-31$1.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-27, accession 0001558370-25-003849.Report this figurenot reportednot reportednot reported28.3Cash and equivalents, Q3 FY2024, at 2024-09-30$28.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001558370-24-015720.Report this figure20.6Cash and equivalents, FY2024, at 2024-12-31$20.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-27, accession 0002006986-26-000003.Report this figure13.0Cash and equivalents, Q1 FY2025, at 2025-03-31$13.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0001558370-25-007883.Report this figure8.2Cash and equivalents, Q2 FY2025, at 2025-06-30$8.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001558370-25-011420.Report this figure4.7Cash and equivalents, Q3 FY2025, at 2025-09-30$4.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001104659-25-110345.Report this figure17.1Cash and equivalents, FY2025, at 2025-12-31$17.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure12.9Cash and equivalents, Q1 FY2026, at 2026-03-31$12.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure7.7Cash and equivalents, Q2 FY2026, at 2026-06-30$7.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure
Current assets$m5.2Current assets, period not labelled, at 2023-12-31$5.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-27, accession 0001558370-25-003849.Report this figurenot reportednot reportednot reported35.0Current assets, Q3 FY2024, at 2024-09-30$35.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001558370-24-015720.Report this figure25.3Current assets, FY2024, at 2024-12-31$25.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-27, accession 0002006986-26-000003.Report this figure17.4Current assets, Q1 FY2025, at 2025-03-31$17.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0001558370-25-007883.Report this figure12.2Current assets, Q2 FY2025, at 2025-06-30$12.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001558370-25-011420.Report this figure8.1Current assets, Q3 FY2025, at 2025-09-30$8.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001104659-25-110345.Report this figure20.1Current assets, FY2025, at 2025-12-31$20.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure15.9Current assets, Q1 FY2026, at 2026-03-31$15.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure10.7Current assets, Q2 FY2026, at 2026-06-30$10.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure
Total assets$m6.8Total assets, period not labelled, at 2023-12-31$6.8m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-27, accession 0001558370-25-003849.Report this figurenot reportednot reportednot reported107Total assets, Q3 FY2024, at 2024-09-30$107.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001558370-24-015720.Report this figure48.4Total assets, FY2024, at 2024-12-31$48.4m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-27, accession 0002006986-26-000003.Report this figure41.3Total assets, Q1 FY2025, at 2025-03-31$41.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0001558370-25-007883.Report this figure35.9Total assets, Q2 FY2025, at 2025-06-30$35.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001558370-25-011420.Report this figure31.5Total assets, Q3 FY2025, at 2025-09-30$31.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001104659-25-110345.Report this figure43.3Total assets, FY2025, at 2025-12-31$43.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure39.3Total assets, Q1 FY2026, at 2026-03-31$39.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure33.9Total assets, Q2 FY2026, at 2026-06-30$33.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure
Current liabilities$m47.2Current liabilities, period not labelled, at 2023-12-31$47.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-27, accession 0001558370-25-003849.Report this figurenot reportednot reportednot reported7.9Current liabilities, Q3 FY2024, at 2024-09-30$7.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001558370-24-015720.Report this figure7.8Current liabilities, FY2024, at 2024-12-31$7.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-27, accession 0002006986-26-000003.Report this figure6.0Current liabilities, Q1 FY2025, at 2025-03-31$6.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001558370-25-007883.Report this figure4.9Current liabilities, Q2 FY2025, at 2025-06-30$4.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001558370-25-011420.Report this figure9.7Current liabilities, Q3 FY2025, at 2025-09-30$9.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001104659-25-110345.Report this figure8.2Current liabilities, FY2025, at 2025-12-31$8.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure8.6Current liabilities, Q1 FY2026, at 2026-03-31$8.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure7.6Current liabilities, Q2 FY2026, at 2026-06-30$7.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure
Total liabilities$m47.4Total liabilities, period not labelled, at 2023-12-31$47.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-27, accession 0001558370-25-003849.Report this figurenot reported0.0Total liabilities, Q2 FY2024, at 2024-06-30$5.0k. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-26, accession 0001410578-24-001560.Report this figurenot reported30.6Total liabilities, Q3 FY2024, at 2024-09-30$30.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001558370-24-015720.Report this figure28.5Total liabilities, FY2024, at 2024-12-31$28.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-27, accession 0002006986-26-000003.Report this figure28.9Total liabilities, Q1 FY2025, at 2025-03-31$28.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0001558370-25-007883.Report this figure27.2Total liabilities, Q2 FY2025, at 2025-06-30$27.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001558370-25-011420.Report this figure32.9Total liabilities, Q3 FY2025, at 2025-09-30$32.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001104659-25-110345.Report this figure30.9Total liabilities, FY2025, at 2025-12-31$30.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure33.6Total liabilities, Q1 FY2026, at 2026-03-31$33.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure34.3Total liabilities, Q2 FY2026, at 2026-06-30$34.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure
Long-term debt$m38.3Long-term debt, period not labelled, at 2023-12-31$38.3m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2025-03-27, accession 0001558370-25-003849.Report this figurenot reportednot reportednot reported13.8Long-term debt, Q3 FY2024, at 2024-09-30$13.8m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-11-14, accession 0001558370-24-015720.Report this figure17.2Long-term debt, FY2024, at 2024-12-31$17.2m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-03-27, accession 0002006986-26-000003.Report this figure17.7Long-term debt, Q1 FY2025, at 2025-03-31$17.7m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-05-15, accession 0001558370-25-007883.Report this figure16.9Long-term debt, Q2 FY2025, at 2025-06-30$16.9m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-08-14, accession 0001558370-25-011420.Report this figure21.2Long-term debt, Q3 FY2025, at 2025-09-30$21.2m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-11-12, accession 0001104659-25-110345.Report this figure21.0Long-term debt, FY2025, at 2025-12-31$21.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure22.9Long-term debt, Q1 FY2026, at 2026-03-31$22.9m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure24.8Long-term debt, Q2 FY2026, at 2026-06-30$24.8m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure
Shareholders' equity$m(132)Shareholders' equity, period not labelled, at 2023-12-31−$132.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-27, accession 0002006986-26-000003.Report this figure(139)Shareholders' equity, period not labelled, at 2024-03-31−$139.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-14, accession 0001558370-25-011420.Report this figure(141)Shareholders' equity, Q2 FY2024, at 2024-06-30−$140.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001104659-25-110345.Report this figure(148)Shareholders' equity, period not labelled, at 2024-07-30−$148.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-27, accession 0002006986-26-000003.Report this figure76.6Shareholders' equity, Q3 FY2024, at 2024-09-30$76.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001104659-25-110345.Report this figure19.9Shareholders' equity, FY2024, at 2024-12-31$19.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure12.4Shareholders' equity, Q1 FY2025, at 2025-03-31$12.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure8.7Shareholders' equity, Q2 FY2025, at 2025-06-30$8.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure(1.3)Shareholders' equity, Q3 FY2025, at 2025-09-30−$1.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001104659-25-110345.Report this figure12.4Shareholders' equity, FY2025, at 2025-12-31$12.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure5.7Shareholders' equity, Q1 FY2026, at 2026-03-31$5.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure(0.4)Shareholders' equity, Q2 FY2026, at 2026-06-30−$415.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure

Cash flow

Operating cash flow−$5.3m, Q2 FY2026
Capital expenditure$6.0k, Q2 FY2026
Adagio Medical Holdings, Inc., cash flow, quarterly
Line itemUnitperiod not labelled2023-12-31period not labelled2024-03-31Q2 FY20242024-06-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(7,091)Operating cash flow, period not labelled, three months to 2023-12-31−$7.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-27, accession 0001558370-25-003849. Derived: 12-month figure less the 9-month figure.Report this figure(6,739)Operating cash flow, period not labelled, three months to 2024-03-31−$6.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001558370-25-007883.Report this figure(6,945)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$6.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001558370-25-011420. Derived: 6-month figure less the 3-month figure.Report this figure(7,211)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure(4,656)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$4.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001104659-26-093790. Derived: 6-month figure less the 3-month figure.Report this figure(3,009)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$3.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001104659-25-110345. Derived: 9-month figure less the 6-month figure.Report this figure(4,138)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$4.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0002006986-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure(4,126)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$4.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure(5,260)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$5.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001104659-26-093790. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k20.0Capital expenditure, period not labelled, three months to 2023-12-31$20.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-27, accession 0001558370-25-003849. Derived: 12-month figure less the 9-month figure.Report this figure162Capital expenditure, period not labelled, three months to 2024-03-31$162.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-15, accession 0001558370-25-007883.Report this figure175Capital expenditure, Q2 FY2024, three months to 2024-06-30$175.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-14, accession 0001558370-25-011420. Derived: 6-month figure less the 3-month figure.Report this figure335Capital expenditure, Q1 FY2025, three months to 2025-03-31$335.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure10.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$10.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001104659-26-093790. Derived: 6-month figure less the 3-month figure.Report this figure520Capital expenditure, Q3 FY2025, three months to 2025-09-30$520.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001104659-25-110345. Derived: 9-month figure less the 6-month figure.Report this figure(491)Capital expenditure, Q4 FY2025, three months to 2025-12-31−$491.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-27, accession 0002006986-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure2.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$2.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure6.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001104659-26-093790. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)22.21m, Q2 FY2026
Adagio Medical Holdings, Inc., shares, quarterly
Line itemUnitQ2 FY20242024-06-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares0.8Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30779,908 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0001558370-25-011420.Report this figure15.4Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3115,375,521 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure15.4Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3015,381,565 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure15.4Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3015,381,565 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001104659-25-110345.Report this figure22.2Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3122,210,459 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001104659-26-059027.Report this figure22.2Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3022,210,459 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure

Shares outstanding: 22.21mShares outstanding, period not labelled, at 2026-08-1022,210,459 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-11, accession 0001104659-26-093790.Report this figure at Aug 10, 2026, from the cover of the 10-Q filed Aug 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. Listed shows no prices and gives no investment advice.